Table N° 3. ICU patients results.
| Ruxolitinib group | SoC group | P | |
|---|---|---|---|
| (n = 19) | (n = 17) | ||
| High flow cannula needing | 6 | 3 | NS (*) |
| N (%) | (31.6%) | (17.6%) | |
| Mechanical ventilation | 13 | 14 | NS |
| (68.4%) | 82.3% | (*) | |
| Hospitalization duration before ICU, days (median, range) | 4 | 5 | NS |
| (1-17) | (0-14) | (**) | |
| Hospitalization in ICU, days (median, range) | 7 | 8 | NS |
| (2-41) | (0-37) | (**) | |
| Deaths (n, %) | 0 (0%) | 5 (29.4%) | 0.05 (*) |
(*) Fisher exact test
(**) U Mann-Whitney test